Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Genapsys

Genapsys

Genapsys is a company developing DNA sequencing technologies and systems founded in 2010 by Hesaam Esfandyarpour.

GenapSys aims to democratize access to Next-Generation Sequencing in order to advance genomics discovery, biomedical research, healthcare, diagnostics, agriculture and other fields.

GenapSys’s priority is to help researchers and clinicians have access to accurate and affordable sequencing at a point closer to patients in order to better treat cancer patients and also fight pandemic outbreaks such as COVID-19 caused by SARS-CoV-2. Other areas with applications to sequencing include food science, personalized medicine and forensics.

GenapSys announced in February, 2020, the launch of its gene sequencer in the Asia Pacific region of Korea, Singapore, Japan and China, in the midst of the Coronavirus outbreak. The company has expanded with 25 distributorship deals and $75 million in financing to scale its global presence. Sequencing is used to study strains and gene mutations in infected individuals to better understand the origin of the virus and containment strategies.

Timeline

May 27, 2021
Genapsys raises a $70,000,000 series D round.
February 6, 2020
Genapsys raises a $75,000,000 venture round from Oxford Finance.
November 2019
Genapsys raises a $90,000,000 series C round from Foresite Capital.
January 15, 2018
Genapsys raises a $32,500,000 series C round.
November 14, 2013
Genapsys raises a $37,000,000 series B round from Decheng Capital, IPV Capital and Yuri Milner.
March 22, 2013
Genapsys raises a $8,500,000 series A round.
October 24, 2012
Genapsys was founded by Hesaam Esfandyarpour.
September 1, 2012
Genapsys raises a $5,500,000 grant.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
July 8, 2021
BioSpace
GenapSys Expands Executive and Leadership Teams with Key New Hires - read this article along with other careers information, tips and advice on BioSpace
June 24, 2021
BioSpace
GenapSysTM Announces Additions to the Company's Executive Team - read this article along with other careers information, tips and advice on BioSpace
GenapSys
June 24, 2021
www.prnewswire.com:443
/PRNewswire/ -- GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of...
GenapSys
June 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the appointment...
GenapSys
May 28, 2021
www.prnewswire.com:443
/PRNewswire/ -- GenapSys, Inc. (GenapSys), ein Unternehmen, das eine hochpräzise und skalierbare elektronische Sequencing-Plattform entwickelt, gab heute...
SHOW MORE
Golden logo
By using this site, you agree to our Terms & Conditions.